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Beta-thalassemiaA number of beta-thalassemia (β-thal) patients in the course of the disease exhibit ectopic calciﬁcation affecting
skin, eyes and the cardiovascular system. Clinical and histopathological features have been described similar to
those in pseudoxanthoma elasticum (PXE), although different genes are affected in the two diseases. Cultured
dermal ﬁbroblasts from β-thal patients with and without PXE-like clinical manifestations have been compared
for parameters of redox balance and for the expression of proteins, which have been already associated with
the pathologic mineralisation of soft connective tissues. Even though oxidative stress is a well-known condition
of β-thal patients, our results indicate that the occurrence of mineralized elastin is associated with a more
pronounced redox disequilibrium, as demonstrated by the intracellular increase of anion superoxide and of
oxidized proteins and lipids. Moreover, ﬁbroblasts from β-thal PXE-like patients are characterized by decreased
availability of carboxylatedmatrix Gla protein (MGP), aswell as by altered expression of proteins involved in the
vitamin K-dependent carboxylation process. Results demonstrate that elastic ﬁbre calciﬁcation is promoted
when redox balance threshold levels are exceeded and the vitamin K-dependent carboxylation process is
affected decreasing the activity ofMGP, a well-known inhibitor of ectopic calciﬁcation. Furthermore, independently
from the primary gene defect, these pathways are similarly involved in ﬁbroblasts from PXE and from β-thal
PXE-like patients as well as in other diseases leading to ectopic calciﬁcation, thus suggesting that can be used
as markers of pathologic mineralisation.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Beta-thalassemias (β-thal) comprise a group of hereditary blood
disorders characterized by abnormal synthesis of haemoglobin β-chains
exerting into variable phenotypes ranging from life-threatening anaemia
to clinically asymptomatic individuals, thus suggesting the existence of
modiﬁers genes [1]. Regular transfusion therapy, although essential for
adequate management of severely affected patients, is also responsible
for a variety of iron overload-related manifestations such as endocrine
complications, myocardiopathy and liver ﬁbrosis, all contributing
to increase morbidity and mortality. Several studies reported that
approximately 16% of patients with major or intermediate β-thal
display progressive skin, eye and vessel pathologies similar toes, University of Modena and
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lino).
ights reserved.those observed in pseudoxanthoma elasticum (PXE), a genetic dis-
ease in which soft connective tissues are speciﬁcally affected [2–6].
Consistently, ultrastructural studies on dermal biopsies clearly
demonstrated that calciﬁcation of elastic ﬁbres, deposition of ab-
normal matrix constituents in the extracellular space and abnormal
collagen ﬁbrillogenesis are analogous in these β-thal patients and
in PXE [7]. Despite these similarities, β-thal is caused by mutations
in the β-globin gene, whereas PXE is associated with mutations in
the ABCC6 gene encoding for the membrane transporter MRP6
[8–10]. Analysis of the ABCC6 gene in a number of β-thal patients,
either with or without PXE manifestations, did not reveal any muta-
tion, thus excluding a digenic inheritance [11]. It was suggested that
the clinical phenotype and the morphological features in PXE and in
β-thal might be the result of abnormalities affecting similar metabol-
ic pathways independently from the gene defect [12]. Recent inves-
tigation in a β-thal mouse model demonstrated that these animals
are characterized by a signiﬁcant NF-E2-dependent down-regulation
of the Abcc6 gene and protein, and it was suggested that a similar tran-
scriptional regulation might occur also in humans [13], even though, in
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or additional factors may be necessary to have a pathologic calciﬁcation
phenotype [13].
To further investigate on themineralisation of elastic ﬁbres in β-thal
and to look for markers that could be associated to the occurrence of
ectopic calciﬁcation, parameters of oxidative stress and the expression
of the calciﬁcation inhibitor matrix Gla protein (MGP) were analysed
in dermal ﬁbroblasts cultured from β-thal patients with and without
PXE-like manifestations. We have previously demonstrated that these
parameters are altered in PXE compared to control ﬁbroblasts and we
have therefore hypothesized that similar alterations may play a role in
other ectopic mineralisation diseases [14–16].
2. Materials and methods
2.1. Patients and cells
In accordance with the guidelines of the Institutional Medical
Ethical Committee and of the Helsinki Declaration of 1975 revised
in 1983, dermal biopsies were obtained, after informed consent, from
the axilla of 6 subjects affected by β-thal major (age 30 ± 6 yr) and
from 6 subjects affected by β-thal major with PXE-like clinical manifes-
tations (age 36 ± 8 yr).
All patients had started blood transfusion treatment within the ﬁrst
year of life, underwent splenectomy and, at present, undergo regular
chelation therapy. Serum calcium and phosphate were within the
normal range. β-Thal PXE-like patients had angioid streaks as well
as lax and redundant skin on the neck and on the axillaewith coalescent
papules. Consistently, dermal biopsies were positive for the von Kossa
stain. All patients were negative for ABCC6mutations [11].
As additional reference controls, ﬁbroblasts from 3 subjects
not exhibiting any sign of connective or haematologic diseases
(age 34 ± 6) and from3 PXE patients (age 39 ± 7)were used. Diagnosis
of pseudoxanthoma was performed on the basis of clinical symptoms
and conﬁrmed by ABCC6 mutations.
From each dermal bioptic sample, ﬁbroblast cultures were
established and grown as previously described [17].
2.2. Flow cytometry assays
Conﬂuent ﬁbroblasts, grown in DMEM with 10% foetal bovine
serum (FBS), were incubated with appropriate ﬂuorescent markers
and analysed on an EPICS XL ﬂow cytometer (Coulter, USA), using a
WINMDI 2.8 programme.
Intracellular levels of O2- • were estimated by incubating ﬁbroblasts
with 1 mM dihydroethidium probe (DH2) (Molecular Probes, USA),
whereas for H2O2 detection, trypsinized cells were stained with 2 mM
H2DCF-DA (Molecular Probes) [16].
2.3. Total Antioxidant Status (TAS)
The total antioxidant capacity of cell lysate was estimated using the
commercial kit ‘Total Antioxidant Status’ (Randox, UK), adapted to the
autoanalyser Cobas Mira (ABX, France), which measures at 600 nm
the formation of the radical cation ABTS•+ using the Reagent ABTS® in
the presence of H2O2 and peroxidase [18].
2.4. Advanced oxidation protein products (AOPP)
AOPP were evaluated on cell lysates as a measure of the degree of
oxidant mediated protein damage [19]. Conﬂuent cells were cultured
for 24 h with complete DMEM supplemented with 0.5% bovine serum
albumin. A microassay adapted to Cobas Mira [20] from the original
method of Witko-Sarsat [21] was used.2.5. Lipid hydroperoxides (LOOH)
LOOH have been evaluated as indicators of lipid peroxidation
as they are intermediates of peroxidative reactions induced by
hydroxyl radicals and singlet oxygen on unsaturated phospholipids,
glycolipids and cholesterol [22]. LOOH were measured using the FOX2
method [23] adapted to Cobas Mira (wavelength 600 nm) [20]. LOOH
was calculated using a standard curve of tert-butylhydroperoxide.
2.6. Malondialdehyde (MDA)
MDA was determined by HPLC on cell extracts incubated with 1 ml
of 0.5% thyobarbituric acid and 0.75 ml of 0.1 N NaOH [24]. Subsequent
treatments were carried out as described by Lepage [25]. Spectro-
photometric reading was done at 490 and 600 nm wavelength.
2.7. Global DNA methylation
DNA was obtained from each cell line using the standard phenol–
chloroform extraction method. Bisulﬁte modiﬁcation was performed
as previously described [26]. The method is based on the ability of
sodium bisulﬁte to selectively deaminate cytosine but not 5-
methylcytosine to uracil. Once this conversion has taken place, sequence
differences between methylated and un-methylated cytosines can be
exploited by direct sequencing and restriction digestion with MboI
(Fermentas) [16].
2.8. Superoxide dismutase (SOD) activities
SOD activities were determined at 37 °C using the commercial kit
“Ransod” (Randox) [20]. Cu–Zn-SOD activity was differentiated from
Mn-SOD on the basis of its sensitivity to 3 mM sodium cyanide.
To analyse EC-SOD activity, the medium of cultured ﬁbroblasts
was concentrated 15-fold using the protein concentration spin columns
(VIVASPIN 20, 10 000 WMCO, Sartorius, Germany) and samples
processed as previously described [20,27].
2.9. Glutathione-S-transferase (GST) and glutathione peroxidase (GPX)
activities
GST activity was measured according to Habig [28] using the
substrate 1-chloro-2, 4-dinitrobenzene (CDNB) and monitoring
absorbance changes at 340 nm [29].
GPX activity was determined at 37 °C using the commercial kit
‘Ransel’ (Randox). One activity unit was deﬁned as the oxidation of
1 μmol NADPH to NADP/min at 37 °C [29].
2.10. Western blot
For 1D-Western blot, protein concentration was measured
according to Bradford [30], thereafter 30 μg proteins were loaded
on 10% polyacrylamide gel under reducing conditions and then
transferred to nitrocellulose according to standard protocols [16].
Primary antibodies against PDI and CALU were diluted in TBST
1:1000 and 1:100, respectively, whereas appropriate horseradish
peroxidase-conjugated secondary antibodies (Abcam, UK) were
used diluted 1:5000. Western blots were visualized using Super Signal
West Pico (Pierce, USA). Densitometry of protein bands was performed
using the ImageQuant TL v2005 software (GE Healthcare, USA).
For 2D-Western blot, conﬂuent cells were trypsinised and then
sonicated on ice in a Soniﬁer B-12 (Branson Sonic Power Company,
USA) with 20 pulses of 2 s. The membrane-enriched fraction, obtained
by centrifuging supernatant at 229 000 ×g for 60 min (Beckman Instru-
ments, USA), was stored frozen at−80 °C until use. Proteins extracted
from a pool of ﬁbroblasts derived from twelve β-thal patients with
(n = 6) and without (n = 6) PXE-like manifestations were used for
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Primary antibodies against uncarboxylated-matrix Gla protein
(Glu-MGP) and carboxylated-matrix Gla protein (Gla-MGP) [31,32]
were used diluted 1:10000 in TBST plus 1% BSA. Anti-mouse IgG
conjugated with horseradish peroxidase (GE HealthCare) and diluted
1:20000 were used as secondary antibodies. Immunoreaction was
revealed by using the SuperSignal West Pico Chemoluminescent
Substrate (Pierce) and normalized to β-actin.
2.11. Ultrastructure
Skin biopsies, cut into small fragments, were routinely ﬁxed in 2.5%
glutaraldehyde (Electron Microscopy Sciences, USA) in Tyrode's buffer,
post-ﬁxed in 1% osmium tetroxide (Fluka AG Chem, Swizerland),
dehydrated in ethanol and then in propylene oxide and embedded in
Spurr resin (Polysciences, USA). Ultrathin sections, obtained from the
epidermis through the reticular dermis, were observed under a
JEM-1200EXII transmission electron microscope (Jeol, Japan).
2.12. Immmuno-electron-microscopy
For MGP immune-localisation on mineralized elastic ﬁbres,
ultrathin sections from dermal biopsies of β-thal-PXE patients were
processed as already described [15]. Sections were ﬁrstly incubated
over night at 4 °C with primary antibodies towards the non-
carboxylated and the carboxylated forms of MGP [31,32] and thereafter
with secondary antibodies conjugated with 10 nm gold particles (EY
Laboratories, USA) for 3 h at room temperature. Observations were
made with a JEM-1200EXII transmission electron microscope (Jeol).
2.13. Statistical analyses
Results are expressed as means of data from each cell lines in
duplicate experiments ± standard deviation (SD), unless other-
wise speciﬁed. Statistical differences were determined using the
MannWhitney test (GraphPad Prism software 5.0) and signiﬁcance
was assigned as p b 0.05.
3. Results
3.1. Parameters of oxidative stress in cultured ﬁbroblasts
The amount of ROSwasmeasured in the cellular monolayer by ﬂow
cytometry (Table 1). Fibroblasts from β-thal PXE-like patients had a
signiﬁcantly higher content of anion superoxide compared toﬁbroblasts
from β-thal patients (p b 0.05), whereas changes were negligible for
hydrogen peroxide.
To verify whether ROS levels in β-thal PXE-like cells were high
enough to induce cellular damages, intermediate and end-products ofTable 1
Parameters of redox balance in ﬁbroblasts from patients with β-thalassemia (β-thal) and
with β-thal and PXE-like manifestations (β-thal PXE-like).
β-thal1 β-thal PXE-like1 p value
O2•-(arbitrary units) 100 ± 3.1 116 ± 10 b0.05
H2O2 (arbitrary units) 100 ± 3.8 107 ± 19 n.s
AOPP (nmol/1 × 106 cells) 16.77 ± 4.7 22.78 ± 4.9 b0.05
LOOH (nmol/1 × 106 cells) 0.585 ± 0.08 0.654 ± 0.02 b0.05
MDA (pmol/mg protein) 5.30 ± 0.6 7.44 ± 2.7 b0.05
TAS (μmol/1 × 106 cells) 0.075 ± 0.002 0.070 ± 0.009 n.s
OX/AntiOX ratio2 (arbitrary unit) 100 ± 20 145 ± 24 b0.05
1 Data are expressed as mean values ± SD of experiments performed two times in
duplicate with all cell lines.
2 The oxidant/antioxidant ratio (OX/AntiOX ratio) is the ratio between parameters of
oxidative damage (AOPP, LOOH and MDA) and antioxidant properties (TAS).lipid peroxidation, as well as oxidized proteins, were measured [22]
(Table 1). Values of LOOH and MDA were higher in β-thal PXE-like ﬁ-
broblasts compared to β-thal cells and a similar accumulation was
observed also for the advanced oxidation protein products (AOPP)
(Table 1). By contrast, the Total Antioxidant Status (TAS) was similar
in all cell lines (Table 1). Consequently, the oxidant/antioxidant ratio
(OX/AntiOX ratio) between parameters related to oxidative damage
(AOPP, LOOH and MDA) and to the antioxidant properties (TAS) of
the cells was signiﬁcantly altered in β-thal PXE-like cells in favour of a
pro-oxidant status (Table 1).
Evaluation of changes in total DNA methylation appeared not
signiﬁcant in all cell strains (data not shown), even if changes at
speciﬁc promoters cannot be excluded.
Measurements of the activity of enzymes regulating the intracellular
redox equilibrium revealed that mitochondrial Mn-SOD was similar in
all cell strains (Fig. 1), whereas cytoplasmic Cu–Zn-SOD, glutathione
S-transferase (GST) and glutatione peroxidase (GPX) activities were
signiﬁcantly higher in β-thal PXE-like compared to β-thal ﬁbroblasts
(Fig. 1). To be noted, however, that the ratio between Cu–Zn-SOD/
GPX was markedly up-regulated in β-thal PXE-like cells indicating
that the increase was not of the same extent for the two parameters.
Moreover, EC-SOD activity measured in the culture medium was
signiﬁcantly higher in β-thal PXE-like compared to β-thal cultures
(Fig. 1).
3.2. Expression of proteins related to the vitamin K-dependent
carboxylation
By 1D and 2D-WB,β-thal PXE-like ﬁbroblasts had lower levels of PDI
and higher expression of CALU in comparison with β-thal cells (Fig. 2).
In the case of CALU, antibodies stained two bands representing the
glycosylated and the non-glycosylated protein, respectively. Densito-
metric analysis performed on both bands indicated that in β-thal PXE-
like cells the glycosylated (i.e. active form) was more intense.
Since both PDI and CALU are involved in the carboxylation of MGP,
un-carboxylated (Glu) and carboxylated (Gla) MGP were evaluated by
2D-WB using speciﬁc antibodies upon normalisation towards the β-
actin content (Fig. 2). Glu-MGP was more abundant in β-thal PXE-like
ﬁbroblasts compared to β-thal, whereas the amount of Gla-MGP
was higher in β-thal compared to β-thal PXE-like cells.
3.3. Immuno-electron microscopy of MGP on mineralized elastic ﬁbres
In normal dermal biopsies, elongated elastic ﬁbres were located
between collagen bundles in close proximity to ﬁbroblasts (Fig. 3a).
By contrast, in β-thal skin specimens, elastic ﬁbres were characterized
by irregular contours with sporadic small mineral precipitates in the
amorphous core (Fig. 3b), as those described at the ultrastructural
level in PXE heterozygous healthy carriers [33].
In β-thal PXE-like patients the majority of elastic ﬁbres exhibit
abundant homogeneous tiny precipitates, as well as bulky deforming
mineral aggregates (Fig. 3c, d).
The localisation of Glu- and Gla-MGP to calciﬁed elastic ﬁbres was
evaluated by immuno-electron microscopy on ultrathin sections of
dermal biopsies from β-thal PXE-like patients. Antibodies recognising
Glu-MGP strongly reacted with polymorphous calciﬁed areas and with
the ﬁnely dispersed calciﬁed core of elastic ﬁbres (Fig. 4a, b). By
contrast, antibodies towards Gla-MGP were localized at the inter-
face between mineralized and normal elastin (Fig. 4c, d), similarly
to observations made on PXE calciﬁed elastic ﬁbres [15].
4. Discussion
A number (approximately 16%) of β-thal patients suffer from
clinical complications due to progressive ectopic calciﬁcation, lead-
ing to a PXE-like phenotype, in the absence of ABCC6 mutations
Fig. 1.Manganese- (Mn-SOD), copper–zinc- (Cu–Zn-SOD) and extracellular (EC-SOD) superoxide dismutase activities, glutathione-S-transferase (GST) and glutathione peroxidase (GPX)
activities as well as the ratio Cu–Zn-SOD/GPX have been measured in ﬁbroblasts from β-thalassemia (β-thal) patients with and without PXE-like (PXE-L) manifestations. Data are
expressed as mean values ± SD of three experiments performed in duplicate using all cell lines. *p b 0.05; **p b 0.01.
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be regarded as a valuable model to investigate the occurrence of
pathologic mineralisation [34] and that in PXE, a disease which is
considered a paradigm of ectopic calciﬁcation, oxidative stress and
vitamin K-related proteins are involved in the pathologic calciﬁc
phenotype [16].
Therefore, in the present study we have investigated dermal
ﬁbroblasts from β-thal patients, with and without PXE-like mani-
festations, in order to look for parameters that could discriminate
the two phenotypes and may be associated to ectopic calciﬁcation.
Altered redox balance, for instance, could signiﬁcantly contribute
to changes in ﬁbroblast behaviour [35], to the severity of clinical
manifestations in several disorders including PXE [14,20] and to
elastic tissue injury [36,37]. It has been actually demonstrated that,
in β-thal patients, both iron overload and plasmamembrane micropar-
ticles derived from the oxidative damage of red cell membranes could
elicit inﬂammatory and oxidative reactions [38,39]. Consistently, the
occurrence of an oxidative stress condition was associated with an
abnormal morphology of elastic ﬁbres in all β-thal patients. Since 16%ofβ-thal patients exhibit also elasticﬁbre calciﬁcation,wehave compared
ﬁbroblasts from β-thal patients with and without ectopic mineralisation
in order to highlight difference in the redox-balance of these cells.
In β-thal PXE-like ﬁbroblasts, compared to β-thal cells, there is an
increased amount of ROS, in particular O2- •. This redox disequilibrium
can be due to higher production of ROS and/or to the inability of cells
to counteract oxidative stress. However, a general failure of antioxidant
mechanisms in β-thal PXE-like is unlikely, as increased Cu–Zn-SOD,
GPX and GST activities are actually elevated in response to sublethal
levels of oxidant pressure. GPX catalyses the reduction of lipid hydro-
peroxides and, at low concentration, of H2O2 and SOD reduces the abil-
ity of superoxide to form strong oxidants and nitrating agents. However,
these two enzymes must increase in a well balanced way, as low SOD
relative to GPX might lead to an accumulation of O2- •. By contrast, high
levels of SOD relative to GPX could lead to increased production of
H2O2 intermediates that may be responsible for the additional produc-
tion of noxius ROS [40]. In β-thal PXE-like cells we have found that
the SOD/GPX ratio was signiﬁcantly increased, thus contributing to al-
tered cellular functions. Moreover, GST and GPX enhancement does
Fig. 2. Representative immunoblots of protein disulﬁde isomerase (PDI), calumenin
(CALU), uncarboxylated- (Glu-) and carboxylated- (Gla-) matrix Gla protein
(MGP) on proteins isolated from ﬁbroblasts from β-thalassemia (β-thal) patients
with and without PXE-like (PXE-L) manifestations. Histograms represent mean
values expressed as percentage of densitometric values ± SD with β-thal values
set at 100. *p b 0.05 β-thal PXE-L vs β-thal values obtained in each cell strain
analysed in duplicate in two experiments. #p b 0.05 β-thal PXE-L vs β-thal values
obtained in duplicate from a pool of ﬁbroblasts, thus indicating experimental
variability.
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with the above described data, AOPP, LOOH andMDA are signiﬁcantly in-
creased in cultured ﬁbroblasts from β-thal PXE-like patients compared to
β-thal ﬁbroblasts, thus leaving unaffected the total antioxidant power
measured in these cells.
An additional target and also source of ROS is the endoplasmic
reticulum (ER). In dermal biopsies of β-thal PXE-like patients,
ﬁbroblasts exhibit cisternae of the ER ﬁlled with electrondense ma-
terial [7]. Interestingly, the vitamin K-dependent γ-carboxylation
of Matrix Gla protein (MGP), one of the most efﬁcient inhibitors
of calcium precipitation, takes place in the ER [41,42].
In this study, we have demonstrated in vitro and ex vivo that low
amount of carboxylated MGP is present in β-thal PXE-like ﬁbroblast's
cultures and on mineralized areas of dermal elastic ﬁbres. In Fig. 5a
data from the present study are compared with those obtained in PXE
compared to control ﬁbroblasts [15]. In both cases, the occurrence of ec-
topic calciﬁcations is associated to a marked reduction of carboxylatedMGP. Additionally, in β-thal PXE-like compared to β-thal cells, CALU
and PDI are up- and down-regulated, respectively. PDI plays a funda-
mental role in protein folding and trafﬁcking and, to be functional, it
must be present in the reduced form [43]. Moreover, PDI, providing
electrons to the VKOR system, interacts with part of the VKORC1 pool
forming, on membranes of the endoplasmic reticulum, the active
warfarin-sensitive Vitamin K N O reducing complex of the vitamin K
cycle [44]. If the level of PDI is reduced and/or the protein is oxidised
by ROS, as it could happen in the high oxidative environment of β-thal
PXE-like ﬁbroblasts, the recycling of vitamin K is impaired and protein
γ-carboxylation may be reduced [45].
Furthermore, in β-thal PXE-like ﬁbroblasts we have also found a
signiﬁcant up-regulation of calumenin, an ER chaperonewith inhibitory
activity on both γ-carboxylase and VKORC1 [46] and consequently on
MGP carboxylation [47].
Dermal ﬁbroblasts from β-thal PXE-like patients exhibit functional
alterations similar to those of ﬁbroblasts isolated from patients with
inherited PXE (higher oxidative stress and reduced carboxylation of
the calciﬁcation inhibitor MGP) suggesting that these altered parame-
ters could be taken as potential markers for the occurrence of ectopic
calciﬁcations. As shown in Fig. 5b ectopic calciﬁcation occurs at higher
levels of redox disequilibrium. Looking in details at the activity of several
antioxidant enzymes, there are some dissimilarities in ﬁbroblasts from
PXE and fromβ-thal PXE-like patients, consistentlywith the involvement
of different genes, although leading to analogousmineralisation of elastic
ﬁbres and to similarly altered parameters (i.e. oxidative stress and low
MGP carboxylation).
Furthermore, data support the hypothesis that serum factor(s) as
well as mesenchymal cells (e.g. dermal ﬁbroblasts) are involved in the
occurrence of ectopic calciﬁcation. Consistently, in both PXE and β-
thal PXE-like patients ﬁbroblasts grown in culture in a controlled envi-
ronment exhibit and maintain pathologic characteristics. Since it has
been shown that dermal ﬁbroblasts do not express ABCC6/MRP6, at
least at signiﬁcant levels, their phenotype could be the result of
epigenetic regulation and/or of a favourable genetic background
rendering these cells more susceptible to calciﬁcation inducers/
stimuli.
Evidence in the animal models already disclosed the importance
of Abcc6 deregulation in the pathogenesis of PXE [48,49] and possibly
of PXE-like manifestations [13]. Actually, the occurrence of oxidative
stress and/or of insufﬁcient MGP carboxylation cannot be directly
related to different levels of ABCC6 expression in β-thal patients,
since this parameter can be evaluated only in tissues/cells highly ex-
pressing the gene (i.e. liver cells). Nevertheless, present data support
the hypothesis that, at least in human dermal ﬁbroblasts, starting
from mutations in different genes (HBB and ABCC6), elastic ﬁbre
mineralisation is associated with common pathways. Slightly lower
ABCC6 expression, either due to NF-E2-mediated transcriptional reg-
ulatory mechanisms [13], as it could be in β-thal patients, or due to
the presence of only one functional allele [33], as in PXE carriers,
may affect elastin metabolism and morphology, without causing
severe calciﬁcation.
Additional factors are necessary to inducemesenchymal cells to alter
their behaviour and to favour themineralisation of the elastic component.
Within this context, altered redox balance and low MGP carboxylation
could be good candidates and may be regarded as markers of ectopic
calciﬁcation contributing to the severity of clinical manifestations in
β-thal, as already demonstrated in PXE [14,20].
5. Conclusion
Studies on dermal ﬁbroblasts cultured from β-thal patients with and
without PXE-like manifestations demonstrate that the occurrence of a
chronic oxidative stress condition is associated to an altered, possibly
functionally damaging, morphology of elastic ﬁbres. However, in order
to have ectopic calciﬁcation threshold levels must be exceeded.
Fig. 3. Transmission electron microscopy of dermal elastic ﬁbres (E) in normal subjects (a) and in β-thalassemia (β-thal) patients with (c, d) and without (b) PXE-like manifestations.
Mineralization (arrows) is limited to tiny small deposits in β-thal patients (b), whereas it dramatically affects and deforms elastic ﬁbres in β-thal PXE-like patients (c–d). Bar = 1 μm.
2082 F. Boraldi et al. / Biochimica et Biophysica Acta 1832 (2013) 2077–2084Furthermore, loss or insufﬁcient availability of carboxylated MGP
is associated to pathologic mineralisation, consistently with the
importance of this calciﬁcation inhibitor, as demonstrated in otherFig. 4. Immuno-electron-microscopy shows the different localization of uncarboxylated- (a, b) a
β-thalassemia patients with PXE-like manifestations. Epitopes are visible as electrondensdifferent pathologic conditions as PXE [15], GGCX mutation associated
disorders [50], vascular calciﬁcation [41,42] and chronic kidney disease
[47].nd carboxylated- (c, d)matrix Gla protein on mineralized elastic ﬁbres in the dermis of
e colloidal gold particles. Bar = 0.5 μm.
Fig. 5. Levels of carboxylated- (Gla-) matrix Gla protein (MGP) evaluated by 2D-Western
blot are reported for ﬁbroblasts from controls and PXE patients as well as from β-
thalassemia (β-thal) patients with and without PXE-like manifestations (a). Parameters
of redox balance (glutathione-S-trasferase, GST; glutathione peroxidase, GPX; ex-
tracellular (EC-SOD), copper–zinc- (Cu–Zn-SOD) andmanganese- (Mn-SOD) superoxide
dismutase activities, as well as the oxidant/antioxidant ratio, AOPP + LOOH + MDA/
TAS) in ﬁbroblasts from patients affected by PXE, β-thal and β-thal PXE-like diseases are
compared with those in ﬁbroblasts from healthy subjects set at 1 (b).
2083F. Boraldi et al. / Biochimica et Biophysica Acta 1832 (2013) 2077–2084In the light of these results, high oxidative stress and low carboxylat-
ed MGP can be considered potential markers of ectopic calciﬁcation in
β-thal patients, as well as in other ectopic calciﬁcation disorders.
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